The future of autologous stem cell transplantation in myeloma Journal Article


Authors: Van Rhee, F.; Giralt, S.; Barlogie, B.
Article Title: The future of autologous stem cell transplantation in myeloma
Abstract: Autologous stem cell transplantation (ASCT) has long been considered frontline therapy for newly diagnosed myeloma patients. This Spotlight examines the role of ASCT in th eera of novel drugs and argues that ASCT should continue to be considered for eligible patients. A combination of novel drugs with ASCT in a sequential treatment approach can attain long-term survival and perhaps cure a subset of patients. ASCT will likely remain an important platform to develop curative strategies in the foreseeable future. © 2014 by The American Society of Hematology.
Journal Title: Blood
Volume: 124
Issue: 3
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2014-07-17
Start Page: 328
End Page: 333
Language: English
DOI: 10.1182/blood-2014-03-561985
PROVIDER: scopus
PUBMED: 24894774
PMCID: PMC4102706
DOI/URL:
Notes: Export Date: 1 August 2014 -- CODEN: BLOOA -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sergio Andres Giralt
    1051 Giralt